18:58 IST
BSE
Results Update
Alivus Life Sciences Results Update
Alivus Life Sciences reported Q1 FY27 financial highlights with revenue growing 6.4% YoY to Rs. 6,404 million and PAT rising 31.8% YoY.
Alivus Life Sciences Ltd
- Share price
- ₹1,384.70
- Market cap
- ₹17,000 Cr
- Revenue (annual)
- ₹2,552 Cr
- Net profit (annual)
- ₹564.5 Cr
- P/E (TTM)
- 28.2×Sector 47.4×
- Promoter holding
- 74.87%+0.00% QoQ
- FII holding
- 5.54%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 5Financial Results 4Results Update 2Merger & Restructuring 2Employee Stock Options 2Board Meeting Date 2Annual General Meeting 2Other Announcement 1Debt & Borrowing 1Business Update 1Annual Report 1
Time
2 announcements with these filters
19:59 IST
NSE
Results Update
Alivus Life Sciences Results Update
Alivus Life Sciences reported FY26 revenue growth of 6.9% YoY and EBITDA margins of 33.6%. The company also announced a new R&D centre in Taloja.